(Q34117850)

31 July 2017

1 reference

title

Guillain-Barré syndrome (GBS). (English)

1 reference

31 July 2017

Guillain–Barré syndrome

0 references

author name string

Anand B Pithadia

series ordinal

1

1 reference

PubMed ID

20508277

31 July 2017

Nimisha Kakadia

series ordinal

2

1 reference

31 July 2017

1 March 2010

1 reference

31 July 2017

Pharmacological Reports

1 reference

31 July 2017

62

1 reference

31 July 2017

2

1 reference

31 July 2017

220-232

1 reference

The epidemiology of Guillain-Barré syndrome

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Assessment of current diagnostic criteria for Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré syndrome and its relationship to swine influenza vaccination in Michigan, 1976-1977

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Electrophysiological changes in the acute "axonal" form of Guillain-Barre syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Clinical presentation and outcome of Guillain–Barré and related syndromes in relation to anti-ganglioside antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Antibodies to ganglioside GM1 in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Distinct pattern of age-specific incidence of Guillain-Barré syndrome in Harbin, China

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Electrophysiology in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré syndrome and head trauma. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré syndrome following acute head trauma

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré syndrome: quantitative measurement of plasma exchange therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

An Unusual Variant of Acute Idiopathic Polyneuritis (Syndrome of Ophthalmoplegia, Ataxia and Areflexia)

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré syndrome secondary to cranial surgery: direct or fortuitous relationship?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Treatment of immune-mediated inflammatory neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Intravenous immunoglobulin and Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Stress and immunity in humans: a meta-analytic review

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré syndrome following cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Pathogenesis of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

No Association Between Immunization and Guillain-Barré Syndrome in the United Kingdom, 1992 to 2000

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Clinical and epidemiologic features of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Supportive care for patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Controlled trial prednisolone in acute polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré Syndrome and the 1978–1979 Influenza Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Relationships between anti-ganglioside antibodies and clinical characteristics of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré Syndrome After Influenza Vaccination in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Comprehensive Analysis of Bacterial Risk Factors for the Development of Guillain‐Barré Syndrome afterCampylobacter jejuniEnteritis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Antiglycolipid antibodies in Guillain-Barré syndrome and autoimmune neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré syndrome: epidemiology, pathophysiology and management

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré syndrome following facial bone fracture.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Rehabilitation of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Rehabilitation outcomes of patients who have developed Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Therapeutic plasma exchange: complications and management

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Pain in central and peripheral demyelinating disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Pain in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Sensory Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Venous and arterial thrombosis following administration of intravenous immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Magnetic resonance imaging of nerve root inflammation in the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Cell-mediated immunity in severely head-injured patients: the role of suppressor lymphocytes and serum factors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré syndrome following coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Treatment of Guillain-Barré syndrome with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Current therapeutic options in severe Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

The use of steroids in the treatment of idiopathic polyneuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré syndrome: multifactorial mechanisms versus defined subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Guillain-Barré syndrome: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

CSF filtration is an effective treatment of Guillain-Barré syndrome: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Carbohydrate mimicry: a new paradigm of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970261-9

7 January 2021

10.1016/S1734-1140(10)70261-9

Identifiers

DOI

1 reference

release_raarerxribbuzjlzpwvrobmvoe

31 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/raarerxribbuzjlzpwvrobmvoe

24 November 2022

mapped directly with Wikidata item

PubMed ID

20508277

1 reference

PubMed ID

20508277